Sales Closing Techniques: What Each One Assumes About the Buyer

A rep runs a clean assumptive close at the end of a good second call. "I'll get the paperwork over this afternoon and we can have you live by the first." The buyer says she will need to run it past her operations lead and probably legal. That is not an objection, and no closing technique in the canon has anything to say about it, because every technique in the canon was designed for a person who could say yes in the room.

Closing techniques are worth knowing. They are a compact library of ways to make a decision easier to say out loud, and several of them are genuinely useful. What they are not is the thing that decides a B2B close, and the reason is visible in what each one quietly assumes.

The techniques, and what each one assumes

Every named close in the standard lists is a small piece of social engineering aimed at a specific friction. Naming the friction is more useful than naming the close.

The assumptive close. You describe the next steps as agreed rather than asking whether they are. "I'll send the order form over and we'll start onboarding Tuesday." It removes the awkwardness of a yes having to be said explicitly, and it works when the decision is genuinely made and nobody wants a ceremony. It assumes one person can act.

The summary close. You restate what the buyer said they needed, then what was agreed the product does about each of those things, then ask. It is the least manipulative of the set and the one most likely to survive scrutiny afterwards, because it is really just accurate note-taking read back. It assumes the needs were captured correctly in the first place, which is a discovery problem rather than a closing one.

The trial close, or test close. A question asked mid-conversation to find out where you actually are, before you get to the end. "If we could get the migration done inside the quarter, is there anything else that would stop this going ahead?" Its whole value is that it surfaces disagreement early enough to do something about it, and it is the technique most worth using habitually.

The alternative choice close. Two options, neither of them no. "Would you rather start with the two-team pilot or the whole department?" It works on scheduling and on genuinely comparable configurations. It reads as a trick on the decision itself, because it is one, and buyers who have been sold to before recognise it.

The urgency close. A reason to decide now: a price change, an implementation slot, a quarter boundary. Honest urgency is real and worth stating plainly. Manufactured urgency is the fastest way to lose a deal you were going to win, and the tell is that the deadline moves when the buyer does not.

The takeaway close. You remove something, usually by suggesting the buyer might be better served by the smaller package or by nothing at all. It works because it breaks the pattern where the seller wants the deal more than the buyer does. Used cynically it is a bluff, and it is called more often than sellers expect.

The test-drive close. Let them use it. A trial, a pilot, a sandbox. This is the only close on the list that substitutes evidence for persuasion, and in software it has quietly eaten most of the others. The design question underneath it, which is what you give away and how the giveaway creates an obligation rather than a habit, is worked through in try before you buy.

The balance-sheet close. Write the reasons for and against in two columns and work through them together. It is slow, it suits analytical buyers, and it has the unusual property of sometimes correctly telling both parties that the answer is no. Most lists give it a famous name, and the name is decoration; the mechanic is the part that does the work.

Removes awkwardnessAssumptive, alternative choice

• The buyer has decided and does not want a ceremony
• Needs one person who can act alone
• Reads as a trick when the decision is not really made

Removes ambiguitySummary, trial close

• Restates or tests what was actually agreed
• Needs discovery to have captured the right things
• Safe to use habitually, and cheap when it fails

Removes inertiaUrgency, takeaway

• Gives the decision a reason to happen now
• Needs the reason to be true
• A deadline that moves teaches the buyer to wait

The assumption they share

Read the list again and one condition appears under all of it: someone in the conversation can say yes.

In a small purchase that is usually true. In most B2B software and services purchases above a few thousand a year it is not, and the number of people who have to agree grows with the price, the length of the commitment and the amount of other people's work the change creates. The person you are closing is frequently the person who will have to go and sell it internally, which is a different job requiring different material.

That reframes what a good close is for. It is not extracting a yes from the buyer. It is making sure the buyer leaves the call able to reproduce your argument to somebody who was not on it. A summary close does that well because it hands them the argument in their own words. An alternative-choice close does not, because it produces a decision without a reason attached.

The frameworks that exist to track this are qualification frameworks rather than closing ones. MEDDIC and MEDDPICC are largely a list of the things that decide a close and are established long before the closing conversation: who the economic buyer is, what the paper process looks like, whether there is an internal champion who can carry it. A deal that fails on those does not fail at the close, it fails at the close visibly.

Where deals are actually decided

Three things predict a B2B close better than closing skill, and all three sit upstream.

Whether the meeting should have happened. A meeting booked with somebody who does not own the problem cannot be closed by any technique, and the effort spent trying is the most expensive thing a sales team does with its week. The test is applied at booking rather than at closing, and the practice of running the first call so that it disqualifies well is set out in the discovery call.

Whether the objections were surfaced or deferred. Objections that arrive at the close were usually available much earlier and were not asked for. A rep who runs trial closes throughout a cycle rarely meets a surprise at the end. The library of standard answers, and the harder question of which ones earn their place, is in objection handlers.

Whether anything is actually moving. Most deals that do not close were never moving, and the stage they are parked in flatters them because stage boundaries are rarely enforced. That diagnosis, and what to do about a pipeline full of them, is in pipeline acceleration.

Is this deal closeable at all

• ✓Yes: The person on the call owns the problem the product solves
• ✓Yes: You can name everyone else who has to agree
• ✓Yes: The buyer can restate your argument without you in the room
• ✓Yes: Every objection you know about has been said out loud
• ~Depends: The purchase has a real internal process and you know its shape
• ~Depends: Any urgency in play is true and survives being questioned
• ~Depends: Nothing has changed in the account since the first conversation

The origin of the phrase everyone quotes

The canon's most famous instruction is "always be closing", and it is worth knowing where it came from.

It is not from a sales textbook. It is a speech written for the 1992 film of Glengarry Glen Ross, delivered by Alec Baldwin's character Blake, and it does not appear in the David Mamet stage play that won the Pulitzer Prize. Mamet wrote the scene for the screen. Collider's account of Baldwin's recollection, published in Vanity Fair, has Mamet explaining that he needed something to ratchet up the pressure on the salesmen, because they were not people otherwise inclined to commit a crime.

The speech exists to explain why decent men start stealing. Taking it as a maxim is reading the villain's lines as the moral.

The practical version of the same instinct, stripped of the cruelty, is the trial close: keep asking where you are, so that the answer at the end is not a surprise to either party.

What closing looks like where we sit

RevenueFlow does not close deals for clients. We run cold email and LinkedIn outbound and book meetings, and the client's own people take the conversation from there, so what follows is our documented policy about the boundary rather than a claim about anyone's close rate.

The boundary matters for a specific reason. Meetings are the billable unit, and what counts as qualified is agreed in writing before anything sends: the company fits the profile, the person has real responsibility for the area, they agreed to a relevant conversation, and they turned up. Budget, timing and decision authority are never billing conditions, because all three are unknowable from outside and unstable from inside, and a standard that requires them rejects the accounts most worth talking to. That reasoning is set out at length in qualified lead marketing.

The consequence for closing is that the first meeting is designed to be a real conversation with a relevant person, and no more than that. What a technique cannot do is convert a conversation with the wrong person into a deal, so the honest place to spend effort is on who is in the room.

The short version

Closing techniques are a library of ways to make a decision easier to say. The summary close and the trial close are the two worth using constantly, because both are really forms of accuracy. The urgency close works exactly as long as the urgency is true. Every technique in the canon assumes a buyer who can act alone, which in B2B is usually the assumption that fails.

The deal is decided by whether the right person was in the first meeting, whether the objections came out early, and whether the buyer can carry your argument into a room you are not in. If the first of those three is the constraint, we will build one campaign against your list and you can judge the meetings.

The Glengarry Glen Ross attribution above is per Collider's report of Alec Baldwin's account in Vanity Fair, read 22 August 2026.